Amwill Health Care FY26 Revenue Up 12%, Profit Flat; Declares ₹0.50 Dividend

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Amwill Health Care FY26 Revenue Up 12%, Profit Flat; Declares ₹0.50 Dividend
Overview

Amwill Health Care reported a 12.1% revenue increase to ₹45.49 crore for FY26. However, net profit remained flat at ₹10.73 crore. The company declared a ₹0.50 per share dividend and fully utilized its IPO proceeds. Auditors noted a cybersecurity incident with an 'Emphasis of Matter'.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Amwill Health Care Reports FY26 Growth Amid Flat Profit and Cybersecurity Note

Amwill Health Care Limited's revenue from operations for FY26 stood at ₹45.49 crore, marking a 12.1% increase from ₹40.58 crore in FY25.

Net profit for FY26 remained unchanged at ₹10.73 crore, mirroring the previous year's performance. Basic Earnings Per Share (EPS) saw a decline of 13.9% to ₹5.71 from ₹6.63 in FY25.

Reader Takeaway: Revenue growth driven by IPO fund use contrasts with flat profit and a cybersecurity incident risk.

What just happened

Amwill Health Care Limited announced its audited financial results for the fiscal year ending March 31, 2026 (FY26). The company reported a revenue of ₹45.49 crore, up 12.1% year-on-year. However, its net profit remained stagnant at ₹10.73 crore. The company also recommended a final dividend of ₹0.50 per share. Auditors issued an 'Emphasis of Matter' regarding a cybersecurity incident that occurred in February 2026, affecting account backups.

Why this matters

While revenue growth is positive, the flat profit and declining EPS suggest potential margin pressures or increased costs. The dividend payout is a shareholder-friendly move. The cybersecurity incident highlighted by auditors, though addressed with data reconstruction and an unmodified opinion, signals an operational risk that warrants investor attention.

The backstory

Amwill Health Care Limited had previously raised funds through an IPO. The company has now reported the full utilization of these IPO proceeds, amounting to ₹48.88 crore, towards working capital, marketing, general corporate purposes, and issue expenses. The company operates in the healthcare sector.

What changes now

Investors will closely monitor the company's ability to translate revenue growth into profit growth in the upcoming fiscal year. The cybersecurity incident necessitates a focus on the company's data security and business continuity plans. The dividend payout provides some immediate return to shareholders.

Risks to watch

The primary risk highlighted is the operational disruption and potential data integrity concerns stemming from the cybersecurity incident. Flat profitability despite revenue growth also indicates potential underlying cost management challenges or competitive pressures.

Peer comparison

(No specific peer comparison data is available in the filing.)

Context metrics (time-bound)

  • IPO Proceeds Utilization: ₹48.88 crore fully utilized.
  • Dividend: ₹0.50 per share recommended for FY26.
  • Cybersecurity Incident Date: February 18, 2026.

What to track next

Investors should track future financial results for profit growth, management's commentary on margin improvement strategies, and updates on cybersecurity measures and business resilience.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.